Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger J Daly

Showing results (21-30 of 143) with videos related to

Pageof 15
Sort By:
Pharmacology & Therapeutics|October 16, 2014
FAK signaling in human cancer as a target for therapeuticsBrian Y Lee, Paul Timpson, Lisa G Horvath, et al.
Biochimica Et Biophysica Acta|March 30, 2010
DUSP26 negatively affects the proliferation of epithelial cells, an effect not mediated by dephosphorylation of MAPKsKate I Patterson, Tilman Brummer, Roger J Daly, et al.
Critical Reviews in Oncogenesis|August 22, 2022
Novel Therapeutic Targets and Biomarkers Associated with Prostate Cancer-Associated Fibroblasts (CAFs)Kimberley C Clark, Yunjian Wu, Renea A Taylor, et al.
Cancer Research|April 19, 2005
Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptorPaul Timpson, Danielle K Lynch, Daniel Schramek, et al.
The Journal of Biological Chemistry|March 12, 2026
A tandem recruitment site in the pseudokinase scaffold PEAK3 is subject to phosphorylation-dependent regulation and cancer-associated mutationsTianyue Zhao, Jianmei Hou, Changyuan Hu, et al.
EMBO Reports|October 5, 2010
Growth factor receptor-bound protein 14: a new modulator of photoreceptor-specific cyclic-nucleotide-gated channelVivek K Gupta, Ammaji Rajala, Roger J Daly, et al.
Proteomics|February 6, 2021
Proteomics-based interrogation of the kinome and its implications for precision oncologyTerry C C Lim Kam Sian, Anderly C Chüeh, Roger J Daly
Journal of Cellular Biochemistry|November 4, 2005
Cell cycle control in breast cancer cellsC Elizabeth Caldon, Roger J Daly, Robert L Sutherland, et al.
Molecular and Cellular Biology|September 1, 2010
Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cellsDavid R Croucher, Danny Rickwood, Carole M Tactacan, et al.
Molecular Oncology|April 16, 2024
Proteome-based molecular subtyping and therapeutic target prediction in gastric cancerChangyuan Hu, Jiangning Song, Terry Kwok, et al.
Pageof 15

Showing results (21-30 of 143) with videos related to

Sort By:
Pageof 15
Pharmacology & Therapeutics|October 16, 2014
FAK signaling in human cancer as a target for therapeuticsBrian Y Lee, Paul Timpson, Lisa G Horvath, et al.
Biochimica Et Biophysica Acta|March 30, 2010
DUSP26 negatively affects the proliferation of epithelial cells, an effect not mediated by dephosphorylation of MAPKsKate I Patterson, Tilman Brummer, Roger J Daly, et al.
Critical Reviews in Oncogenesis|August 22, 2022
Novel Therapeutic Targets and Biomarkers Associated with Prostate Cancer-Associated Fibroblasts (CAFs)Kimberley C Clark, Yunjian Wu, Renea A Taylor, et al.
Cancer Research|April 19, 2005
Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptorPaul Timpson, Danielle K Lynch, Daniel Schramek, et al.
The Journal of Biological Chemistry|March 12, 2026
A tandem recruitment site in the pseudokinase scaffold PEAK3 is subject to phosphorylation-dependent regulation and cancer-associated mutationsTianyue Zhao, Jianmei Hou, Changyuan Hu, et al.
EMBO Reports|October 5, 2010
Growth factor receptor-bound protein 14: a new modulator of photoreceptor-specific cyclic-nucleotide-gated channelVivek K Gupta, Ammaji Rajala, Roger J Daly, et al.
Proteomics|February 6, 2021
Proteomics-based interrogation of the kinome and its implications for precision oncologyTerry C C Lim Kam Sian, Anderly C Chüeh, Roger J Daly
Journal of Cellular Biochemistry|November 4, 2005
Cell cycle control in breast cancer cellsC Elizabeth Caldon, Roger J Daly, Robert L Sutherland, et al.
Molecular and Cellular Biology|September 1, 2010
Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cellsDavid R Croucher, Danny Rickwood, Carole M Tactacan, et al.
Molecular Oncology|April 16, 2024
Proteome-based molecular subtyping and therapeutic target prediction in gastric cancerChangyuan Hu, Jiangning Song, Terry Kwok, et al.
Pageof 15